TNF and inflammatory bowel disease: In particular, in the literature, it has been seen that anti-TNF drugs, widely used in the therapy of IBD, have a potential protective effect against COVID-19 symptoms due to a higher production of Tregs and, consequently, of anti-inflammatory cytokines.